VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 361 filers reported holding VANECK VECTORS ETF TR in Q2 2016. The put-call ratio across all filers is 1.14 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $633,000 | +60.3% | 23,698 | +53.7% | 0.00% | +50.0% |
Q2 2019 | $395,000 | +9.1% | 15,418 | -4.7% | 0.00% | 0.0% |
Q1 2019 | $362,000 | +7.7% | 16,177 | +1.6% | 0.00% | 0.0% |
Q4 2018 | $336,000 | +9.4% | 15,928 | -3.9% | 0.00% | 0.0% |
Q3 2018 | $307,000 | -13.5% | 16,581 | +4.1% | 0.00% | 0.0% |
Q2 2018 | $355,000 | +0.3% | 15,923 | -1.1% | 0.00% | 0.0% |
Q1 2018 | $354,000 | -9.7% | 16,103 | -4.5% | 0.00% | 0.0% |
Q4 2017 | $392,000 | -55.0% | 16,866 | -55.5% | 0.00% | -60.0% |
Q3 2017 | $871,000 | +198.3% | 37,926 | +186.0% | 0.01% | +150.0% |
Q2 2017 | $292,000 | -60.9% | 13,259 | -59.5% | 0.00% | -60.0% |
Q1 2017 | $746,000 | +10.7% | 32,761 | +1.5% | 0.01% | +25.0% |
Q4 2016 | $674,000 | +119.5% | 32,261 | +177.3% | 0.00% | +100.0% |
Q3 2016 | $307,000 | -6.1% | 11,635 | -1.7% | 0.00% | 0.0% |
Q2 2016 | $327,000 | – | 11,835 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |